<code id='B225F46F90'></code><style id='B225F46F90'></style>
    • <acronym id='B225F46F90'></acronym>
      <center id='B225F46F90'><center id='B225F46F90'><tfoot id='B225F46F90'></tfoot></center><abbr id='B225F46F90'><dir id='B225F46F90'><tfoot id='B225F46F90'></tfoot><noframes id='B225F46F90'>

    • <optgroup id='B225F46F90'><strike id='B225F46F90'><sup id='B225F46F90'></sup></strike><code id='B225F46F90'></code></optgroup>
        1. <b id='B225F46F90'><label id='B225F46F90'><select id='B225F46F90'><dt id='B225F46F90'><span id='B225F46F90'></span></dt></select></label></b><u id='B225F46F90'></u>
          <i id='B225F46F90'><strike id='B225F46F90'><tt id='B225F46F90'><pre id='B225F46F90'></pre></tt></strike></i>

          entertainment

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Biotech stock slump in 2023: awaiting the turnaround
          Biotech stock slump in 2023: awaiting the turnaround

          AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Drug for rare kidney disease narrowly misses mark in clinical trial

          AdobeTravereTherapeuticssaidThursdaythatastudymeanttoconfirmthebenefitofitsnewlyapproveddrugforarare